Characterization of the retinal pigment epithelium in Friedreich ataxia

Duncan Edward Crombie; Nicole J Van Bergen; Kathryn Cherise Davidson; Sara Anjomani-Virmouni; Penny A McKelvie; Vicki Chrysostomou; Alison Conquest; Louise Anne Corben; Mark A Pook; Tejal Kulkarni; Ian A Trounce; Martin Frederick Pera; Martin Delatycki; Alice Pebay

doi:10.1016/j.bbrep.2015.09.003

Characterization of the retinal pigment epithelium in Friedreich ataxia

Duncan Edward Crombie
, Nicole J Van Bergen
, Kathryn Cherise Davidson
, Sara Anjomani-Virmouni
, Penny A McKelvie
, Vicki Chrysostomou
, Alison Conquest
, Louise Anne Corben
, Mark A Pook
, Tejal Kulkarni
, Ian A Trounce
, Martin Frederick Pera
, Martin Delatycki
, Alice Pebay

School of Psychological Sciences

Research output: Contribution to journal › Article › Research › peer-review

11 Citations (Scopus)

Abstract

We assessed structural elements of the retina in individuals with Friedreich ataxia (FRDA) and in mouse models of FRDA, as well as functions of the retinal pigment epithelium (RPE) in FRDA using induced pluripotent stem cells (iPSCs). We analyzed the retina of the FRDA mouse models YG22R and YG8R containing a human FRATAXIN (FXN) transgene by histology. We complemented this work with post-mortem evaluation of eyes from FRDA patients. Finally, we derived RPE cells from patient FRDA-iPSCs to assess oxidative phosphorylation (OXPHOS) and phagocytosis. We showed that whilst the YG22R and YG8R mouse models display elements of retinal degeneration, they do not recapitulate the loss of retinal ganglion cells (RGCs) found in the human disease. Further, RPE cells differentiated from human FRDA-iPSCs showed normal OXPHOS and we did not observe functional impairment of the RPE in Humans

Original language	English
Pages (from-to)	141-147
Number of pages	7
Journal	Biochemistry and Biophysics Reports
Volume	4
DOIs	https://doi.org/10.1016/j.bbrep.2015.09.003
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.bbrep.2015.09.003Licence: CC BY

3541762-oaFinal published version, 1.83 MBLicence: CC BY

Cite this

Crombie, D. E., Van Bergen, N. J., Davidson, K. C., Anjomani-Virmouni, S., McKelvie, P. A., Chrysostomou, V., Conquest, A., Corben, L. A., Pook, M. A., Kulkarni, T., Trounce, I. A., Pera, M. F., Delatycki, M., & Pebay, A. (2015). Characterization of the retinal pigment epithelium in Friedreich ataxia. Biochemistry and Biophysics Reports, 4, 141-147. https://doi.org/10.1016/j.bbrep.2015.09.003

@article{fe473372918b4a2188b598e81236eac9,

title = "Characterization of the retinal pigment epithelium in Friedreich ataxia",

abstract = "We assessed structural elements of the retina in individuals with Friedreich ataxia (FRDA) and in mouse models of FRDA, as well as functions of the retinal pigment epithelium (RPE) in FRDA using induced pluripotent stem cells (iPSCs). We analyzed the retina of the FRDA mouse models YG22R and YG8R containing a human FRATAXIN (FXN) transgene by histology. We complemented this work with post-mortem evaluation of eyes from FRDA patients. Finally, we derived RPE cells from patient FRDA-iPSCs to assess oxidative phosphorylation (OXPHOS) and phagocytosis. We showed that whilst the YG22R and YG8R mouse models display elements of retinal degeneration, they do not recapitulate the loss of retinal ganglion cells (RGCs) found in the human disease. Further, RPE cells differentiated from human FRDA-iPSCs showed normal OXPHOS and we did not observe functional impairment of the RPE in Humans",

author = "Crombie, \{Duncan Edward\} and \{Van Bergen\}, \{Nicole J\} and Davidson, \{Kathryn Cherise\} and Sara Anjomani-Virmouni and McKelvie, \{Penny A\} and Vicki Chrysostomou and Alison Conquest and Corben, \{Louise Anne\} and Pook, \{Mark A\} and Tejal Kulkarni and Trounce, \{Ian A\} and Pera, \{Martin Frederick\} and Martin Delatycki and Alice Pebay",

year = "2015",

doi = "10.1016/j.bbrep.2015.09.003",

language = "English",

volume = "4",

pages = "141--147",

journal = "Biochemistry and Biophysics Reports",

issn = "2405-5808",

publisher = "Elsevier BV",

}

Crombie, DE, Van Bergen, NJ, Davidson, KC, Anjomani-Virmouni, S, McKelvie, PA, Chrysostomou, V, Conquest, A, Corben, LA, Pook, MA, Kulkarni, T, Trounce, IA, Pera, MF, Delatycki, M & Pebay, A 2015, 'Characterization of the retinal pigment epithelium in Friedreich ataxia', Biochemistry and Biophysics Reports, vol. 4, pp. 141-147. https://doi.org/10.1016/j.bbrep.2015.09.003

TY - JOUR

T1 - Characterization of the retinal pigment epithelium in Friedreich ataxia

AU - Crombie, Duncan Edward

AU - Van Bergen, Nicole J

AU - Davidson, Kathryn Cherise

AU - Anjomani-Virmouni, Sara

AU - McKelvie, Penny A

AU - Chrysostomou, Vicki

AU - Conquest, Alison

AU - Corben, Louise Anne

AU - Pook, Mark A

AU - Kulkarni, Tejal

AU - Trounce, Ian A

AU - Pera, Martin Frederick

AU - Delatycki, Martin

AU - Pebay, Alice

PY - 2015

Y1 - 2015

N2 - We assessed structural elements of the retina in individuals with Friedreich ataxia (FRDA) and in mouse models of FRDA, as well as functions of the retinal pigment epithelium (RPE) in FRDA using induced pluripotent stem cells (iPSCs). We analyzed the retina of the FRDA mouse models YG22R and YG8R containing a human FRATAXIN (FXN) transgene by histology. We complemented this work with post-mortem evaluation of eyes from FRDA patients. Finally, we derived RPE cells from patient FRDA-iPSCs to assess oxidative phosphorylation (OXPHOS) and phagocytosis. We showed that whilst the YG22R and YG8R mouse models display elements of retinal degeneration, they do not recapitulate the loss of retinal ganglion cells (RGCs) found in the human disease. Further, RPE cells differentiated from human FRDA-iPSCs showed normal OXPHOS and we did not observe functional impairment of the RPE in Humans

AB - We assessed structural elements of the retina in individuals with Friedreich ataxia (FRDA) and in mouse models of FRDA, as well as functions of the retinal pigment epithelium (RPE) in FRDA using induced pluripotent stem cells (iPSCs). We analyzed the retina of the FRDA mouse models YG22R and YG8R containing a human FRATAXIN (FXN) transgene by histology. We complemented this work with post-mortem evaluation of eyes from FRDA patients. Finally, we derived RPE cells from patient FRDA-iPSCs to assess oxidative phosphorylation (OXPHOS) and phagocytosis. We showed that whilst the YG22R and YG8R mouse models display elements of retinal degeneration, they do not recapitulate the loss of retinal ganglion cells (RGCs) found in the human disease. Further, RPE cells differentiated from human FRDA-iPSCs showed normal OXPHOS and we did not observe functional impairment of the RPE in Humans

U2 - 10.1016/j.bbrep.2015.09.003

DO - 10.1016/j.bbrep.2015.09.003

M3 - Article

C2 - 29124197

SN - 2405-5808

VL - 4

SP - 141

EP - 147

JO - Biochemistry and Biophysics Reports

JF - Biochemistry and Biophysics Reports

ER -